Clinical Trial Update: Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of oxaliplatin and pemetrexed disodium in patients with refractory hormone-resistant prostate cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: University of Southern California | Conditions: Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-12-11